Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1364
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1A comparative analysis of immunohistochemistry and fluorescent in situ hybridization assay to detect anaplastic lymphoma kinase status in lung adenocarcinoma cases: A search for a testing algorithm
PB Wagle,NA Jambhekar,R Kumar,K Prabhash,CS Pramesh,SB Desai,V Noronha,G Karimundackal,A Shah,A Joshi,SG Laskar,S Jiwnani,T Pai,JP Agarwal
Indian Journal of Cancer.2017;54(1)148
[DOI]
2Comparing four different ALK antibodies with manual immunohistochemistry (IHC) to screen for ALK -rearranged non-small cell lung cancer (NSCLC)
Qin Shen,Xuan Wang,Bo Yu,Shanshan Shi,Biao Liu,Yanfen Wang,Qiuyuan Xia,Qiu Rao,Xiaojun Zhou
Lung Cancer.2015;90(3)492
[DOI]
3Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India
Aditya Navile Murali,Venkatraman Radhakrishnan,Trivadi S. Ganesan,Rejiv Rajendranath,Prasanth Ganesan,Ganesarajah Selvaluxmy,Rajaraman Swaminathan,Shirley Sundersingh,Arvind Krishnamurthy,Tenali Gnana Sagar
Journal of Global Oncology.2017;3(5)459
[DOI]
4Anaplastic lymphoma kinase status in lung cancers: An immunohistochemistry and fluorescence in situ hybridization study from a tertiary cancer center in India
SS Murthy,SJ Rajappa,SD Gundimeda,KM Mallavarapu,S Ayyagari,P Yalavarthi,D Fonseca,P Paliwal,HGR Nair,V Koppula,KVVN Raju,ST Rao
Indian Journal of Cancer.2017;54(1)231
[DOI]
5Personalized medicine: Lung Cancer leads the way
P Parikh,T Puri
Indian Journal of Cancer.2013;50(2)77
[DOI]
6Evolving concepts in lung cancer pathology and its impact on thoracic oncology practice
Nirmala Jambhekar
Indian Journal of Thoracic and Cardiovascular Surgery.2018;34(S1)4
[DOI]
7Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing
Kumar Prabhash,Suresh H. Advani,Ullas Batra,Bivas Biswas,Anuradha Chougule,Mithua Ghosh,Vamshi Krishna Muddu,T. P. Sahoo,Ashok K. Vaid
Advances in Therapy.2019;36(4)766
[DOI]
8A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study
Vandana Rana,Praveer Ranjan,Rajat Jagani,K.R. Rathi,Dharmesh Kumar,Anurag Khera
Medical Journal Armed Forces India.2018;74(2)148
[DOI]
9Role of crizotinib in c-mesenchymal-epidermal transition-positive nonsmall cell lung cancer patients
U Batra,A Jain,M Sharma,R Bajaj,M Suryavanshis
Indian Journal of Cancer.2017;54(1)178
[DOI]
10Clinical profile of nonsmall cell lung carcinoma patients treated in a single unit at a tertiary cancer care center
DC Doval,R Sinha,U Batra,KD Choudhury,S Azam,A Mehta
Indian Journal of Cancer.2017;54(1)193
[DOI]
11Clinicopathological and Demographical Characteristics of Non-Small Cell Lung Cancer Patients with ALK Rearrangements: A Systematic Review and Meta-Analysis
Liang Fan,Yun Feng,Huanying Wan,Guochao Shi,Wenquan Niu,Christina Lynn Addison
PLoS ONE.2014;9(6)e100866
[DOI]
12Anaplastic lymphoma kinase immunohistochemistry in lung adenocarcinomas: Evaluation of performance of standard manual method using D5F3 antibody
D Jain,K Jangra,PS Malik,S Arulselvi,K Madan,S Mathur,MC Sharma
Indian Journal of Cancer.2017;54(1)209
[DOI]
  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow